QuirieGen

DropPrint Genomics

This company develops single-cell genomics software and an immune cell database for pharmaceutical researchers and biotechnology firms to improve drug discovery processes.

1Cell.Ai

The company develops single-cell multi-omic analysis platforms for oncology researchers and drug developers to monitor therapies, discover biomarkers, and study tumour heterogeneity.

Nygen

This company develops cloud-based data platforms that use artificial intelligence to analyse and interpret single-cell genomic datasets for pharmaceutical and academic research teams.

Phenomic AI

This company develops a machine learning platform for drug discovery through cell imaging and single-cell RNA sequencing for pharmaceutical and biotechnology partners.

Duplicat

This company develops artificial intelligence technology to accelerate molecular discovery and enhance drug compound identification for pharmaceutical businesses.

Deeplife

This company develops a cellular digital twin platform using artificial intelligence and multi-omics data to accelerate drug discovery for biotechnology and pharmaceutical researchers.

Single Cell Discoveries

This company provides single-cell sequencing and spatial transcriptomics services to pharmaceutical, biotechnology and academic organisations to support drug discovery and biological research.

Parallel Bio

This company develops a drug discovery platform using human immune organoids and artificial intelligence for pharmaceutical and biotechnology partners.